Nano-engineered solutions for extensively drug-resistant tuberculosis (XDR-TB): A novel nanomedicine
Authors:
- Dilpreet SinghDSDilpreet Singh
- Vrinda KrishnaVKVrinda Krishna
- Nitya KumariNKNitya Kumari
- Anoushka BanerjeeABAnoushka Banerjee
- Prithviraj KapoorPKPrithviraj Kapoor
- 25 October 2024
- journal article
- Published by Elsevier in Nano-Structures & Nano-Objects
- Vol. 40
Abstract
No abstract availableThis publication has 109 references indexed in Scilit:
- Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosisDrug Delivery and Translational Research, 2021
- Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive propertiesDrug Delivery and Translational Research, 2020
- Dendrimer-based drug delivery systems for tuberculosis treatment2020
- Regulation of engineered nanomaterials: current challenges, insights and future directionsEnvironmental Science and Pollution Research, 2017
- The formulation of nanomedicines for treating tuberculosisAdvanced Drug Delivery Reviews, 2016
- pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in MiceSmall, 2015
- Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticlesJournal of Nanoparticle Research, 2013
- Nature-inspired Novel Drug Design Paradigm Using Nanosilver: Efficacy on Multi-Drug-Resistant Clinical Isolates of TuberculosisCurrent Microbiology, 2010
- Ligand‐Based Virtual Screening, Parallel Solution‐Phase and Microwave‐Assisted Synthesis as Tools to Identify and Synthesize New Inhibitors of Mycobacterium tuberculosisChemMedChem, 2006
- Synthetic and natural polymers as drug carriers for tuberculosis treatmentMacromolecular Symposia, 1998